37 related articles for article (PubMed ID: 38650801)
21. The prognostic significance of tumor epidermal growth factor receptor (EGFR) expression change after neoadjuvant chemoradiation in patients with rectal adenocarcinoma.
Richter I; Dvořák J; Urbanec M; Bluml A; Čermáková E; Bartoš J; Petera J
Contemp Oncol (Pozn); 2015; 19(1):48-53. PubMed ID: 26199571
[TBL] [Abstract][Full Text] [Related]
22. Tumor regression grading of gastrointestinal carcinomas after neoadjuvant treatment.
Thies S; Langer R
Front Oncol; 2013 Oct; 3():262. PubMed ID: 24109590
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of changes of tumor epidermal growth factor receptor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma.
Dvorak J; Sitorova V; Ryska A; Sirak I; Richter I; Hatlova J; Ferko A; Melichar B; Petera J
Strahlenther Onkol; 2012 Sep; 188(9):833-8. PubMed ID: 22847519
[TBL] [Abstract][Full Text] [Related]
24. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.
Sauer R; Liersch T; Merkel S; Fietkau R; Hohenberger W; Hess C; Becker H; Raab HR; Villanueva MT; Witzigmann H; Wittekind C; Beissbarth T; Rödel C
J Clin Oncol; 2012 Jun; 30(16):1926-33. PubMed ID: 22529255
[TBL] [Abstract][Full Text] [Related]
25. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study.
Lee HJ; Xu X; Choe G; Chung DH; Seo JW; Lee JH; Lee CT; Jheon S; Sung SW; Chung JH
Lung Cancer; 2010 Jun; 68(3):375-82. PubMed ID: 19712993
[TBL] [Abstract][Full Text] [Related]
26. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
[TBL] [Abstract][Full Text] [Related]
27. Status of HER1 and HER2 in peritoneal, ovarian and colorectal endometriosis and ovarian endometrioid adenocarcinoma.
Uzan C; Darai E; Valent A; Graesslin O; Cortez A; Rouzier R; Vielh P
Virchows Arch; 2009 May; 454(5):525-9. PubMed ID: 19294416
[TBL] [Abstract][Full Text] [Related]
28. Relationships of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancer.
Takahari D; Yamada Y; Okita NT; Honda T; Hirashima Y; Matsubara J; Takashima A; Kato K; Hamaguchi T; Shirao K; Shimada Y; Shimoda T
Oncology; 2009; 76(1):42-8. PubMed ID: 19033715
[TBL] [Abstract][Full Text] [Related]
29. EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number.
Kim MA; Lee HS; Lee HE; Jeon YK; Yang HK; Kim WH
Histopathology; 2008 May; 52(6):738-46. PubMed ID: 18397279
[TBL] [Abstract][Full Text] [Related]
30. Expression of epidermal growth factor receptor as a predictive factor for rectal cancer.
Motlagh A; Azadeh P; Fazlalizadeh A; Shahrad B; Shafaghi B; Fudazi M; Yosefi A; Davaei M
Arch Iran Med; 2007 Jul; 10(3):301-8. PubMed ID: 17604465
[TBL] [Abstract][Full Text] [Related]
31. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921.
Bosset JF; Calais G; Mineur L; Maingon P; Radosevic-Jelic L; Daban A; Bardet E; Beny A; Briffaux A; Collette L
J Clin Oncol; 2005 Aug; 23(24):5620-7. PubMed ID: 16009958
[TBL] [Abstract][Full Text] [Related]
32. EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations.
Bhargava R; Gerald WL; Li AR; Pan Q; Lal P; Ladanyi M; Chen B
Mod Pathol; 2005 Aug; 18(8):1027-33. PubMed ID: 15920544
[TBL] [Abstract][Full Text] [Related]
33. Role of HER receptors family in development and differentiation.
Casalini P; Iorio MV; Galmozzi E; Ménard S
J Cell Physiol; 2004 Sep; 200(3):343-50. PubMed ID: 15254961
[TBL] [Abstract][Full Text] [Related]
34. HER1/EGFR targeting: refining the strategy.
Pérez-Soler R
Oncologist; 2004; 9(1):58-67. PubMed ID: 14755015
[TBL] [Abstract][Full Text] [Related]
35. Color multiplex polymerase chain reaction for quantitative analysis of epidermal growth factor receptor genes in colorectal adenocarcinoma.
Layfield LJ; Bernard PS; Goldstein NS
J Surg Oncol; 2003 Aug; 83(4):227-31. PubMed ID: 12884235
[TBL] [Abstract][Full Text] [Related]
36. EGFR and cancer prognosis.
Nicholson RI; Gee JM; Harper ME
Eur J Cancer; 2001 Sep; 37 Suppl 4():S9-15. PubMed ID: 11597399
[TBL] [Abstract][Full Text] [Related]
37. The Association of the Epidermal Growth Factor Receptor (EGFR) Immunoexpression With Prognostic Parameters in Adenocarcinoma Patients Receiving Neoadjuvant Treatment.
Demir D; Parvizi M; Pehlivanoglu B; Ergin E; Ayhan S; Doganavsargil B
Cureus; 2024 Mar; 16(3):e56763. PubMed ID: 38650801
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
